Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2025 07:00 ET | Source: CG Oncology Inc.

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

- Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus...
September 03, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology Completes Enrollment in PIVOT-006

– Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) –– One of the largest randomized phase 3 studies in this patient population will...
August 29, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences

IRVINE, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...
August 08, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
July 29, 2025 16:05 ET | Source: CG Oncology Inc.

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
June 05, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 15, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
May 13, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
May 01, 2025 08:00 ET | Source: CG Oncology Inc.

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
April 26, 2025 16:10 ET | Source: CG Oncology Inc.

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at AUA